Evaluation of the immunogenic potential of recombinant Mycobacterium bovis BCG expressing the ASP-2 and TC24 proteins from Trypanosoma cruzi.

Summary: Chagas disease is a serious infection caused by the Trypanosoma cruzi parasite. Current treatments are often ineffective because the disease is hard to diagnose early, and the drugs used have severe side effects. Scientists are now looking for a better solution: prevention through vaccination. In a recent study, researchers modified the BCG vaccine—commonly used against tuberculosis—to carry proteins from the Chagas parasite. When tested on mice, this modified vaccine successfully triggered a strong immune response, producing specific defense cells (cytokines) necessary to fight the infection. This suggests that modifying the safe, well-known BCG vaccine could be a promising new way to protect people from Chagas disease.